The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
ELITA – the European Liver and Intestine Transplant Association – would like to announce a call for nominations for new Board member. All ESOT/ELITA affiliates are welcome to send nominations for this position. You may nominate yourself or a colleague. The new ELITA Board Member will hold office for 4 years (2022-2026), starting September 2022.
In the last 8 weeks, specialised paediatric liver centres in the UK identified more children with acute liver failure due to hepatitis of an unknown cause than would be expected over a similar period.
Read a statement on the outbreak from ELITA
APPLICATIONS NOW OPEN for the 2nd Workshop for Young Professionals in Transplantation on Living Organ Donation on June 16 in Gubbio, Italy The Workshop is organised in combination with the 10th Living Donor Abdominal Transplant Conference on June 17-18 in Gubbio, Italy The first edition of this Workshop was held in 2018 in Matera, Italy, and turned out to be a
Building on the success of recent multi-society collaboration
This initiative builds on the recent success of our multi-society effort: a publication of the findings of a survey we held in 2020 and sent to 470 centres worldwide, serving to explore how patients, healthcare professionals, and liver transplant centres across the world were affected by the first wave of the COVID-19 pandemic.
Hot off the press: findings of our survey on liver transplantation & COVID-19. Jointly run with ESOT, ELITA, EASL, ILTS and published in the Journal of Hepatology.
Join us for the BD Symposium and learn about a successful collaboration of General Surgeon / Abdominal wall specialist Manuel Lopez Cano and Cristina Dopazo Liver- transplant surgeon in the approach to reduce the risk of incisional hernias after liver transplant surgery. You can register here This is part of the ESOT Congress Industry
International Medical Societies representing Transplantation Professionals across the globe support and nurture diversity and inclusion among their members, fostering education, and stand against any form of barriers in access, knowledge, transition and required training around the “Gift of Life”, particularly that related to gender, race, religion and income. We embrace a call of action to
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation Authors: Christophe Duvoux, Luca S. Belli, James Fung, Mario Angelico, Maria Buti, Audrey Coilly, Paolo Cortesi, François Durand, Cyrille Féray, Constantino Fondevila, Pascal Lebray, Silvia Martini, Frederik Nevens, Wojciech G. Polak, Mario Rizzetto, Riccardo Volpes, Fabien Zoulim, Didier Samuel, Marina Berenguer First published: 19 July 2021 – https://doi.org/10.1111/apt.16374
“The liver is the centre and most important organ in the body…for many hundreds of years, the liver was used to give predictions about life and fortunes” – Dr Jan Lerut, retired Professor of Surgery, explains the history of the liver and takes us on a journey through the origins of liver transplantation.
We would like to announce a call for nominations for one new Board member. All ESOT/ELITA affiliates are welcome to send nominations for this position. You may nominate yourself or a colleague. The new ELITA Board Member will hold office for 4 years (2021-2025). Considering the current composition of the Board and with the objective
